RENOVORX, Inc. INDEMNIFICATION AGREEMENTIndemnification Agreement • July 21st, 2021 • RenovoRx, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJuly 21st, 2021 Company Industry JurisdictionThis INDEMNIFICATION AGREEMENT (“Agreement”) is made as of ______, 2021 by and between RenovoRX, Inc., a Delaware corporation (the “Company”), and ____________ (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.
WARRANT AGENT AGREEMENTWarrant Agent Agreement • July 21st, 2021 • RenovoRx, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 21st, 2021 Company Industry JurisdictionThis Warrant Agent Agreement (this “Warrant Agreement”), dated as of ___, 2021 (the “Issuance Date”) between RenovoRx, Inc., a company incorporated under the laws of the State of Delaware (the “Company”), and Philadelphia Stock Transfer, Inc. (the “Warrant Agent”).
RENOVORX, INC. CONSULTING AGREEMENTConsulting Agreement • July 21st, 2021 • RenovoRx, Inc. • Pharmaceutical preparations • California
Contract Type FiledJuly 21st, 2021 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is entered on this ____ day of January 2013 (“Effective Date”) by and among RenovoRx, Inc., a Delaware corporation, and its successors or assignees (“Company”), and Ramtin Agah (referred to herein as “Consultant”) for the purpose of setting forth the terms and conditions by which the Company will acquire Consultant’s services.
RENOVORX, INC. AMENDMENT NO. 1 TORenovoRx, Inc. • July 21st, 2021 • Pharmaceutical preparations • Delaware
Company FiledJuly 21st, 2021 Industry JurisdictionTHIS AMENDMENT NO. 1 (this “Amendment”) to each of those certain Convertible Promissory Notes (collectively, the “Notes”) issued prior to the date hereof pursuant to that certain Note Purchase Agreement dated March 31, 2020, by and among RenovoRx, Inc. (the “Company”) and certain investors of the Company listed on the signature pages thereto (the “Note Purchase Agreement”) is entered into as of this ____ day of March, 2021 (the “Effective Date”). Capitalized terms not defined herein have the meanings set forth in the Note Purchase Agreement or the Notes, as applicable.
Dec. 13, 2020 Paul MannersRenovoRx, Inc. • July 21st, 2021 • Pharmaceutical preparations
Company FiledJuly 21st, 2021 Industry
RENOVORX CONSULTING AGREEMENTRenovorx Consulting Agreement • July 21st, 2021 • RenovoRx, Inc. • Pharmaceutical preparations • California
Contract Type FiledJuly 21st, 2021 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is made as of the Effective Date set forth above by and between RenovoRx, Inc, a Delaware corporation (“Client”) and the consultant named on the signature page hereto (“Consultant”).
Master Supplv AgreementMaster Supplv Agreement • July 21st, 2021 • RenovoRx, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 21st, 2021 Company IndustryThis Master Supply Agreement (the “Agreement” or “MSA”) is entered into on this 28th day of Oct. 2019 (the “Effective Date”) by and between Medical Murray, Inc., an Illinois corporation with a principal place of business at 400 North Rand Road, North Barrington, IL 60010 (the “Supplier”) and RenovoRx, Inc. a Delaware corporation with a principal place of business at 4546 El Camino Real, Suite 223, Los Altos, CA 94022 (the “Buyer”).